抗CASPR2疾病的高复发率:对长期免疫疗法的影响
Tessa Brand1, Suzanne Claudia Franken1, Marie R Vermeiren1
1Department of Neurology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Neurology(R) neuroimmunology & neuroinflammation
|December 16, 2025
概括
抗接触素相关蛋白类2 (CASPR2) 疾病的复发率很高,反复治疗的Rituximab疗程对容易复发的患者最有效. 监测抗VGKC复合体度有助于跟踪疾病进展和复发.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 抗接触素相关蛋白类2 (CASPR2) 疾病,以前是一种抗电压通道 (VGKC-复合体) 脑炎的亚型,是一种新发现的神经系统疾病.
- 关于与CASPR2疾病相关的长期预后和复发率的数据有限.
研究的目的:
- 调查长期临床结果,并确定导致抗CASPR2疾病复发率更高的因素.
- 为了比较不同治疗策略的疗效来管理CASPR2疾病及其复发.
主要方法:
- 一项全国性的观察队列研究,包括44名被诊断患有抗CASPR2疾病的患者.
- 在诊断和随访期间回顾性和前性收集临床数据,包括抗VGKC复合物的度和发作发生率.
主要成果:
- 60%的患者至少有一次复发,有时会出现新的外周神经系统症状.
- 诊断时抗VGKC复合体度较高和发作发生率增加与疾病复发有关.
- 与其他治疗方法相比,重复的利图西马布疗程在预防复发方面表现出显著的有效性 (ARR 0.09).
结论:
- 反CASPR2疾病的复发率明显高于以前所理解的.
- 对于复发性复发的患者来说,重复的Rituximab管理是长期治疗疾病的最有效策略.
- 监测抗VGKC复合体血清度对于评估疾病活性和指导治疗调整是有价值的,在复发时建议重复瘤查.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
459
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
459
Immunological Memory
14.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
14.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
445
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
445
Desensitization and Tachyphylaxis
2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
408
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
408
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

